The New Jersey Devils announced on a conference call that free agent signing Brian Boyle has been diagnosed with a form of bone cancer (Chronic Myeloid Leukemia). The disease was caught early enough that Boyle will be able to treat it with medication, but more tests will be performed. Boyle is “looking forward to getting back on the ice” and his focus is still on October 7th when the season begins.
Boyle was signed to a two-year contract this summer after splitting time between the Tampa Bay Lightning and Toronto Maple Leafs last season, and is generally considered one of the strongest leaders around the NHL. Beloved by his teammates and coaching staffs, there will no doubt be an outpouring of support for him from all around the league. It’s wonderful to hear that he feels largely healthy, and is still committed to starting the season on time.
The 32-year old is expected to play a big role on a team that is looking to make it back to the playoffs this year, solidifying a position that will have several young names vying for spots. The Devils currently figure to have Nico Hischier start the year down the middle, with youngsters Pavel Zacha and John Quenneville potential options. Boyle will likely be used in a bottom-six and penalty killing role, one he has excelled at throughout his career.
Amazingly, Boyle previously wrote a piece profiling his father’s own battle with cancer, and how he has been free of the disease for more than 15 years. Boyle has been involved in the NHL’s Hockey Fights Cancer initiative ever since. As he wrote then:
When it comes to cancer, people don’t always want to talk about it. Unfortunately, it’s often a sad story. But it can also be an inspiring story about people who are fearless in times of adversity, people who have battled and people who are not afraid to put up a fight. Sometimes, it can be a happy story.
Everyone at PHR and around the hockey world is with you Brian. This will be another happy story.